182 related articles for article (PubMed ID: 35848656)
1. Ectopic fat deposition and its related abnormalities of lipid metabolism followed by nonalcoholic fatty pancreas.
Chen Y; Zhang P; Lv S; Su X; Du Y; Xu C; Jin Z
Endosc Ultrasound; 2022; 11(5):407-413. PubMed ID: 35848656
[TBL] [Abstract][Full Text] [Related]
2. Transabdominal ultrasonography of the pancreas is superior to that of the liver for detection of ectopic fat deposits resulting from metabolic syndrome.
Li S; Su L; Lv G; Zhao W; Chen J
Medicine (Baltimore); 2017 Sep; 96(37):e8060. PubMed ID: 28906401
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China.
Weng S; Zhou J; Chen X; Sun Y; Mao Z; Chai K
Medicine (Baltimore); 2018 Jun; 97(26):e11293. PubMed ID: 29953011
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.
Filippatos TD; Alexakis K; Mavrikaki V; Mikhailidis DP
Dig Dis Sci; 2022 Jan; 67(1):26-41. PubMed ID: 33469809
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.
Della Corte C; Mosca A; Majo F; Lucidi V; Panera N; Giglioni E; Monti L; Stronati L; Alisi A; Nobili V
Clin Endocrinol (Oxf); 2015 Nov; 83(5):656-62. PubMed ID: 26201937
[TBL] [Abstract][Full Text] [Related]
6. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
[TBL] [Abstract][Full Text] [Related]
7. [NON-ALCOHOLIC FATTY PANCREATIC DISEASE (NAFPD) AND THE METABOLIC SYNDROME: INITIATING FACTOR OR ADDITIONAL COMPONENT?].
Grigorieva IN; Efimova OV; Tov NL; Suvorova TS
Eksp Klin Gastroenterol; 2015; (9):86-91. PubMed ID: 26931016
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty pancreas disease: An emerging clinical challenge.
Zhang CL; Wang JJ; Li JN; Yang Y
World J Clin Cases; 2021 Aug; 9(23):6624-6638. PubMed ID: 34447810
[TBL] [Abstract][Full Text] [Related]
9. [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].
Jermendy G
Orv Hetil; 2022 Oct; 163(44):1735-1742. PubMed ID: 36309887
[TBL] [Abstract][Full Text] [Related]
10. Type 2 diabetes: Does pancreatic fat really matter?
Guglielmi V; Sbraccia P
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 28984071
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty pancreas disease as a risk factor for pancreatic cancer based on endoscopic ultrasound examination among pancreatic cancer patients: A single-center experience.
Lesmana CRA; Gani RA; Lesmana LA
JGH Open; 2018 Feb; 2(1):4-7. PubMed ID: 30483555
[TBL] [Abstract][Full Text] [Related]
12. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.
Catanzaro R; Cuffari B; Italia A; Marotta F
World J Gastroenterol; 2016 Sep; 22(34):7660-75. PubMed ID: 27678349
[TBL] [Abstract][Full Text] [Related]
13. Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression.
Singh RG; Yoon HD; Wu LM; Lu J; Plank LD; Petrov MS
Metabolism; 2017 Apr; 69():1-13. PubMed ID: 28285638
[TBL] [Abstract][Full Text] [Related]
14. In New-Onset Diabetes Mellitus, Metformin Reduces Fat Accumulation in the Liver, But Not in the Pancreas or Pericardium.
Zsóri G; Illés D; Ivány E; Kosár K; Holzinger G; Tajti M; Pálinkás E; Szabovik G; Nagy A; Palkó A; Czakó L
Metab Syndr Relat Disord; 2019 Jun; 17(5):289-295. PubMed ID: 31013454
[No Abstract] [Full Text] [Related]
15. Non-alcoholic fatty pancreas disease - practices for clinicians.
Pinte L; Balaban DV; Băicuş C; Jinga M
Rom J Intern Med; 2019 Sep; 57(3):209-219. PubMed ID: 30901317
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences.
Dite P; Blaho M; Bojkova M; Jabandziev P; Kunovsky L
Dig Dis; 2020; 38(2):143-149. PubMed ID: 31865317
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic and hepatobiliary manifestations of nonalcoholic fatty pancreatic disease: a referral multi-center experience.
Sbeit W; Greener T; Kadah A; Mari A; Goldin E; Mahamid M; Khoury T
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e297-e301. PubMed ID: 33600093
[TBL] [Abstract][Full Text] [Related]
18. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study.
Wu WC; Wang CY
Cardiovasc Diabetol; 2013 May; 12():77. PubMed ID: 23688357
[TBL] [Abstract][Full Text] [Related]
19. Pancretic Fat Accummulation is Associated with Subclinical Atherosclerosis.
Sahin S; Karadeniz A
Angiology; 2022 Jul; 73(6):508-513. PubMed ID: 34607492
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty pancreas disease and pancreatic exocrine insufficiency: pilot study and systematic review.
Maetzel H; Rutkowski W; Panic N; Mari A; Hedström A; Kulinski P; Stål P; Petersson S; Brismar TB; Löhr JM; Vujasinovic M
Scand J Gastroenterol; 2023; 58(9):1030-1037. PubMed ID: 37088949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
